196 related articles for article (PubMed ID: 1933900)
1. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
2. Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.
Möller P; Momburg F; Koretz K; Moldenhauer G; Herfarth C; Otto HF; Hämmerling GJ; Schlag P
Cancer Res; 1991 Jan; 51(2):729-36. PubMed ID: 1985791
[TBL] [Abstract][Full Text] [Related]
3. Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells.
Pantel K; Schlimok G; Kutter D; Schaller G; Genz T; Wiebecke B; Backmann R; Funke I; Riethmüller G
Cancer Res; 1991 Sep; 51(17):4712-5. PubMed ID: 1873815
[TBL] [Abstract][Full Text] [Related]
4. The role of surface HLA-A,B,C molecules in tumour immunity.
Möller P; Hämmerling GJ
Cancer Surv; 1992; 13():101-27. PubMed ID: 1423320
[TBL] [Abstract][Full Text] [Related]
5. [The expression of leukocytic and related antigens on the cells of human breast cancer cells].
Tupitsyn NN; Kadagidze ZG; Blokhina NG; Baryshnikov AIu; Ermilova VD; Artamonova EV; Moldenhauer G; Bernard A
Eksp Onkol; 1990; 12(2):54-8. PubMed ID: 1690634
[TBL] [Abstract][Full Text] [Related]
6. Expression of polymorphic HLA-A,B epitopes in human urothelial cell lines.
Ottesen SS; Kieler J
Anticancer Res; 1991; 11(1):217-23. PubMed ID: 1708220
[TBL] [Abstract][Full Text] [Related]
7. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva MR; Garrido F
Cancer Res; 1991 May; 51(9):2463-8. PubMed ID: 1849792
[TBL] [Abstract][Full Text] [Related]
8. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Concha A; Esteban F; Cabrera T; Ruiz-Cabello F; Garrido F
Semin Cancer Biol; 1991 Feb; 2(1):47-54. PubMed ID: 1912518
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
10. Loss of colonic HLA antigens in familial adenomatous polyposis.
Tsioulias G; Godwin TA; Goldstein MF; McDougall CJ; Ngoi SS; DeCosse JJ; Rigas B
Cancer Res; 1992 Jun; 52(12):3449-52. PubMed ID: 1317751
[TBL] [Abstract][Full Text] [Related]
11. Can the HLA phenotype be used as a prognostic factor in breast carcinomas?
Concha A; Cabrera T; Ruiz-Cabello F; Garrido F
Int J Cancer Suppl; 1991; 6():146-54. PubMed ID: 2066180
[TBL] [Abstract][Full Text] [Related]
12. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma.
Goepel JR; Rees RC; Rogers K; Stoddard CJ; Thomas WE; Shepherd L
Br J Cancer; 1991 Nov; 64(5):880-3. PubMed ID: 1718386
[TBL] [Abstract][Full Text] [Related]
13. Expression of class II major histocompatibility complex molecules correlates with human colon tumor vaccine efficacy.
Ransom JH; Pelle B; Hanna MG
Cancer Res; 1992 Jun; 52(12):3460-6. PubMed ID: 1596903
[TBL] [Abstract][Full Text] [Related]
14. Reaction patterns of tumor infiltrating lymphocytes in different renal cell carcinomas and oncocytomas.
Störkel S; Keymer R; Steinbach F; Thoenes W
Prog Clin Biol Res; 1992; 378():217-23. PubMed ID: 1363795
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of five new human renal tumor xenografts.
Beniers AJ; Peelen WP; Schaafsma HE; Beck JL; Ramaekers FC; Debruyne FM; Schalken JA
Am J Pathol; 1992 Feb; 140(2):483-95. PubMed ID: 1739137
[TBL] [Abstract][Full Text] [Related]
16. MHC expression on human tumors--its relevance for local tumor growth and metastasis.
Garrido F; Ruiz-Cabello F
Semin Cancer Biol; 1991 Feb; 2(1):3-10. PubMed ID: 1912516
[TBL] [Abstract][Full Text] [Related]
17. Selective and non-selective loss of immunoregulatory molecules (HLA-A,B,C antigens and LFA-3) in transitional cell carcinoma.
Nouri AM; Smith ME; Crosby D; Oliver RT
Br J Cancer; 1990 Oct; 62(4):603-6. PubMed ID: 1699592
[TBL] [Abstract][Full Text] [Related]
18. MHC class I antigen expression is inversely related with tumor malignancy and ras oncogene product (p21ras) levels in human breast tumors.
Solana R; Romero J; Alonso C; Peña J
Invasion Metastasis; 1992; 12(3-4):210-7. PubMed ID: 1294532
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic markers in renal cell carcinoma.
Banner BF; Burnham JA; Bahnson RR; Ernstoff MS; Auerbach HE
Mod Pathol; 1990 Mar; 3(2):129-34. PubMed ID: 1691492
[TBL] [Abstract][Full Text] [Related]
20. Metastasis formation in human solid tumors: phenotypic characteristics of early metastatic cells.
Riethmüller G; Schlimok G; Pantel K; Angstwurm M; Izbicki J; Karg O; Stade BG; Johnson JP
Behring Inst Mitt; 1992 Apr; (91):204-9. PubMed ID: 1355966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
